Comparative effectiveness of different chemotherapeutic regimens on survival of people aged 66 and older with stage III colon cancer: a "real world" analysis using Surveillance, Epidemiology, and End Results-Medicare data.
about
Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancerEffects of being uninsured or underinsured and living in extremely poor neighborhoods on colon cancer care and survival in California: historical cohort analysis, 1996-2011.Surgical treatment of early stage breast cancer in elderly: an international comparison.Colon cancer care and survival: income and insurance are more predictive in the USA, community primary care physician supply more so in Canada.Mediation of the effects of living in extremely poor neighborhoods by health insurance: breast cancer care and survival in California, 1996 to 2011.Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States.Real-world resource use and costs of adjuvant treatment for stage III colon cancer.Recurrence-free and overall survival among elderly stage III colon cancer patients treated with CAPOX or capecitabine monotherapy.Administration of adjuvant chemotherapy for stage II-III colon cancer patients: An European population-based study.Use of adjuvant chemotherapy in patients with stage III colon cancer in Puerto Rico: A population-based study.
P2860
Q24201720-13489B48-46BF-4546-BEAC-BE85D6228423Q34455690-541A5DA6-E2FB-4059-B6D0-F355EE2717AFQ35828253-860D85A6-566A-47B2-9DAB-3A9D6D73348CQ36222636-35EA097B-1F60-4D56-9DFD-7C3CED78FBAAQ36690252-F5CE5E9A-9BDA-4152-8BB5-19150EE16A59Q36910683-5DB612F7-20C4-47A9-BCA4-A5CEF26390EFQ38174218-FEC2F998-C84D-45D6-B7B2-3D393831260EQ40586852-1B353710-1497-4807-A160-57EA9635D551Q48265163-533A9C15-086D-4DFC-AB2F-FF3B3F182201Q55114129-E6E6482A-CD47-4720-88FF-BE15DA78F356
P2860
Comparative effectiveness of different chemotherapeutic regimens on survival of people aged 66 and older with stage III colon cancer: a "real world" analysis using Surveillance, Epidemiology, and End Results-Medicare data.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Comparative effectiveness of d ...... and End Results-Medicare data.
@ast
Comparative effectiveness of d ...... and End Results-Medicare data.
@en
type
label
Comparative effectiveness of d ...... and End Results-Medicare data.
@ast
Comparative effectiveness of d ...... and End Results-Medicare data.
@en
prefLabel
Comparative effectiveness of d ...... and End Results-Medicare data.
@ast
Comparative effectiveness of d ...... and End Results-Medicare data.
@en
P2093
P2860
P1476
Comparative effectiveness of d ...... and End Results-Medicare data
@en
P2093
Ebere Onukwugha
Nader Hanna
Naimish Pandya
P2860
P304
P356
10.1111/J.1532-5415.2011.03501.X
P407
P577
2011-08-10T00:00:00Z